Abstract:Objective To construct prokaryotic expression systems of Staphylococcus enterotoxin A (SEA) gene and its mutants, and to determine the activity changes of recombinant expression products before and after mutation shown by cytotoxicity, promoting lymphocyte proliferation and inhibiting tumor cell growth. Methods sea gene with no signal peptide sequence of S. aureus strain ATCC13565 was amplified and then cloned by using high fidelity PCR and T-A cloning method. The site-specific mutants of sea gene using mutant primers as well as prokaryotic expression systems of the sea gene and its mutants were constructed. Ni-NTA affinity chromatography was performed to extract the expressed target recombinant proteins. The cytotoxicity to Vero cells of the recombi- nant proteins was measured using TCID_(50) titration method. MTT colorimetry was applied to examine the effects of the recombinant proteins at different dosages on promoting proliferation of mouse splenocytes and inhibiting growth of tumor cell lines KB and HL-60. Results The similarity of nucleotide sequence of the cloned sea gene was 100% as compared to the reported SEA sequences and the expected mutation of codons in each seven mutants at the scheduled positions was proved. All the recombiant protein expression outputs of sea gene and its mutants took approximate 52% of the total bacterial proteins. The TCID_(50) of rSEA's cytotoxicity to Vero cells was 4.1μg while the TCID_(50) values of the recombinant of sea gene mutants was 5.8-23.5μg, respectively. One and fiveμg/ml of rSEA and its five mutant proteins rSEA/H187A, rSEA/H225A, rSEA/D227 A, rSEA/H187A/D227A and rSEA/ H225A/D227A showed remarkable effects to promote proliferation of mouse splenocytes (P0.05). The activities of promoting mouse splenocyte proliferation of 10 and 20μg/ml rSEA and the five mutant proteins were similar to that of 100μg/ml PHA (P0.05). The supernatants or the mixture of supematant and splenocytes stimulated by 5-20μg/ml rSEA or each five mutant proteins efficiently inhibited the growth of KB and HL-60 cells (P0.05). Conclusion Since rSEA/H225A, rSEA/D227A and rSEA/H225A/D227A display lower cytotoxicity, stronger pro- moting of splenocyte proliferation and inhibiting tumor cell growth, the recombinant proteins of three mutants are potential candidates for leukogenic and anti-tumor SEA associated drugs.

Sereening and characterization of neutralizing monoclonal antibodies against Staphylococcal enterotoxin B

Structural Basis For The Neutralization And Specificity Of Staphylococcal Enterotoxin B Against Its Mhc Class Ii Binding Site

Production and preliminary application of anti-staphylococcal enterotoxinB monoclonal antibodies

A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B

Identification of a Novel Protective Human Monoclonal Antibody, LXY8, That Targets the Key Neutralizing Epitopes of Staphylococcal Enterotoxin B.

Construction of Eukaryotic Expression System of Staphylococcal Enterotoxin B Gene and Identification of Goal Protein

Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo

Construction of Prokaryotic Expression System of Staphylococcal Enterotoxin B Gene and Effects of Its Expressed Product on Promoting Lymphocyte Proliferation and Inhibiting the Growth of Tumor Cell

Prokaryotic Expression,Purification and Identification of the Biological Effects of Staphylococcal Enterotoxin B

Development of nanobodies against Staphylococcus enterotoxin B through yeast surface display

Expression and Bioactivity Analysis of Staphylococcal Enterotoxin M and N

Structural insights into the binding of nanobodies to the Staphylococcal enterotoxin B

Expression and characterization of single-chain variable fragment antibody against staphylococcal enterotoxin A in Escherichia coli.

Gene detection of staphylococcal enterotoxins in production strain of staphylococcin injection and superantigenic activity of rSEK and rSEQ

Expression and Bioactivity Analysis of Staphylococcal Enterotoxin G and Staphylococcal Enterotoxin I.

Construction and identification of prokaryotic expression system of staphylococcal enterotoxin A gene and expressed product

Computational Construction of a Single-Chain Bi-Paratopic Antibody Allosterically Inhibiting TCR-Staphylococcal Enterotoxin B Binding

Production of a Monoclonal Antibody by Simultaneous Immunization of Staphylococcal Enterotoxin A and B

Establishment and identification of monoclonal antibodies to human Streptococcus suis 2 extracellular factor protein

[Preparation and Application of Antibody Against Staphylococcal Enterotoxin C2].

Construction of Site-Specific Mutants of Staphylococcus Enterotoxin A Gene and Biological Activities of Recombinant Expression Products